Changes in the Relationship Between Plasma Fibrinogen Concentration and Functional Clot Strength After Cardiopulmonary Bypass: A Retrospective Observational Study.
{"title":"Changes in the Relationship Between Plasma Fibrinogen Concentration and Functional Clot Strength After Cardiopulmonary Bypass: A Retrospective Observational Study.","authors":"Yusaku Terada, Kenji Yoshitani, Masahiro Morinaga, Akito Tsukinaga, Soshiro Ogata, Satsuki Fukushima","doi":"10.1053/j.jvca.2025.08.060","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate whether the relationship between plasma fibrinogen concentration (Clauss method) and functional fibrinogen activity as measured by viscoelastic hemostatic assays (VHAs)- thromboelastography-derived citrated functional fibrinogen (CFF) and Quantra-derived fibrinogen contribution to clot stiffness (FCS)-changes before and after cardiopulmonary bypass (CPB).</p><p><strong>Design: </strong>A single-center retrospective observational study.</p><p><strong>Setting: </strong>Cardiovascular surgery center in Japan.</p><p><strong>Participants: </strong>208 adult patients undergoing cardiovascular surgery with CPB.</p><p><strong>Interventions: </strong>No intervention.</p><p><strong>Measurements and main results: </strong>Fibrinogen function was assessed at 3 time points: before CPB (T1), immediately after protamine administration (T2), and 1 hour later (T3). CFF (n = 170) and FCS (n = 79) values, along with plasma fibrinogen concentrations, were collected. For CFF, the regression slope against Clauss fibrinogen increased from 6.12 at T1 to 8.69 at T2 (p < 0.05), then returned to 6.58 at T3. The intercept decreased significantly at T2 (from 0.29 to -8.39), indicating enhanced clot strength per unit of fibrinogen. For FCS, the slope decreased from 1.66 at T1 to 0.61 at T2 and 0.72 at T3, and the intercept increased from -3.55 to -0.32, suggesting persistently reduced fibrinogen contribution post-CPB. Conventional tests showed prolonged prothrombin time/activated partial thromboplastin time, decreased hemoglobin and platelet counts, and elevated thrombin antithrombin complex, fibrin/fibrinogen degradation products, and D-dimer levels, indicating coagulation factor consumption and thrombin generation.</p><p><strong>Conclusions: </strong>The association between fibrinogen concentration and functional clot strength changes significantly after CPB, with contrasting trends in TEG and Quantra. These findings highlight qualitative fibrinogen alterations post-CPB, suggesting that concentration alone might not reflect true coagulative function.</p>","PeriodicalId":15176,"journal":{"name":"Journal of cardiothoracic and vascular anesthesia","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiothoracic and vascular anesthesia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1053/j.jvca.2025.08.060","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To evaluate whether the relationship between plasma fibrinogen concentration (Clauss method) and functional fibrinogen activity as measured by viscoelastic hemostatic assays (VHAs)- thromboelastography-derived citrated functional fibrinogen (CFF) and Quantra-derived fibrinogen contribution to clot stiffness (FCS)-changes before and after cardiopulmonary bypass (CPB).
Design: A single-center retrospective observational study.
Setting: Cardiovascular surgery center in Japan.
Participants: 208 adult patients undergoing cardiovascular surgery with CPB.
Interventions: No intervention.
Measurements and main results: Fibrinogen function was assessed at 3 time points: before CPB (T1), immediately after protamine administration (T2), and 1 hour later (T3). CFF (n = 170) and FCS (n = 79) values, along with plasma fibrinogen concentrations, were collected. For CFF, the regression slope against Clauss fibrinogen increased from 6.12 at T1 to 8.69 at T2 (p < 0.05), then returned to 6.58 at T3. The intercept decreased significantly at T2 (from 0.29 to -8.39), indicating enhanced clot strength per unit of fibrinogen. For FCS, the slope decreased from 1.66 at T1 to 0.61 at T2 and 0.72 at T3, and the intercept increased from -3.55 to -0.32, suggesting persistently reduced fibrinogen contribution post-CPB. Conventional tests showed prolonged prothrombin time/activated partial thromboplastin time, decreased hemoglobin and platelet counts, and elevated thrombin antithrombin complex, fibrin/fibrinogen degradation products, and D-dimer levels, indicating coagulation factor consumption and thrombin generation.
Conclusions: The association between fibrinogen concentration and functional clot strength changes significantly after CPB, with contrasting trends in TEG and Quantra. These findings highlight qualitative fibrinogen alterations post-CPB, suggesting that concentration alone might not reflect true coagulative function.
期刊介绍：
The Journal of Cardiothoracic and Vascular Anesthesia is primarily aimed at anesthesiologists who deal with patients undergoing cardiac, thoracic or vascular surgical procedures. JCVA features a multidisciplinary approach, with contributions from cardiac, vascular and thoracic surgeons, cardiologists, and other related specialists. Emphasis is placed on rapid publication of clinically relevant material.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
